Skip to main content
. 2022 Nov 29;55:101737. doi: 10.1016/j.eclinm.2022.101737

Fig. 4.

Fig. 4

Change in CRP-defined cardiovascular risk category from baseline to week 68. Observed data for the in-trial period (time from randomisation to last contact with the trial site, regardless of treatment discontinuation or rescue intervention) for the full analysis set. Cardiovascular risk categories are defined as serum CRP levels of <1 mg/L (low), 1–3 mg/L (intermediate), and >3 mg/L (high). CRP, C-reactive protein.